SFBarringtonKCL Profile Banner
Sally Barrington Profile
Sally Barrington

@SFBarringtonKCL

Followers
470
Following
219
Media
51
Statuses
281

Nuclear Medicine Physician and NIHR Research Professor. PET enthusiast.

London UK
Joined January 2017
Don't wanna be here? Send us removal request.
@SFBarringtonKCL
Sally Barrington
1 month
RT @mike_dickinson1: Two comprehensive reviews on new bispecific antibodies in #lymphoma made pretty and online @Haematologica #lymsm @Adr….
0
18
0
@SFBarringtonKCL
Sally Barrington
1 month
RT @StefanoLuminari: This is finally out! More to come from the FOLL12 trial by fil #flsm #lymsm.
0
5
0
@SFBarringtonKCL
Sally Barrington
2 months
RT @NIHRresearch: "While the UK is a global leader in clinical research, many solutions to today’s complex health challenges - such as redu….
0
12
0
@SFBarringtonKCL
Sally Barrington
2 months
RT @DrJFriedberg: Timely tour de force review on Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase–Targeted Approaches |….
ascopubs.org
Mantle cell lymphoma (MCL) represents a relatively uncommon, heterogeneous lymphoma associated with limited overall survival. Targeting of the B-cell receptor pathway in relapsed disease with...
0
18
0
@SFBarringtonKCL
Sally Barrington
2 months
RT @DrMHofman: #VIOLET Study of Terbium-161 (Tb-161) Beta/Auger therapy @ASCO #ASCO25. First prospective trial of Terbium-161 in any tumour….
0
46
0
@SFBarringtonKCL
Sally Barrington
3 months
Abstract deadline approaching May31 for submissions to #PILM2025. Come join us to discuss hot topics in lymphoma and myeloma in beautiful Menton France 12-13 September 2025 @AnneSegolene @c_thieblemont @IreneBuvat @AndreaGallamini3 .
Tweet card summary image
linkedin.com
🚨 Call for Abstracts – Deadline: May 31, 2025 🚨 #PILM2025 is getting closer – and once again, we’re bringing together everyone involved in advancing the role of #PET imaging in #Lymphoma and...
0
0
0
@SFBarringtonKCL
Sally Barrington
4 months
RT @DrMHofman: We are seeking a clinical trial co-ordinator who wants to make a true impact. at @PeterMacCC . you’ll lead the coordinatio….
0
12
0
@SFBarringtonKCL
Sally Barrington
5 months
RT @bmj_latest: For the first time ever the UK has more female than male doctors, with 164 440 women (50.04%) and 164 195 men (49.96%) regi….
0
16
0
@SFBarringtonKCL
Sally Barrington
8 months
RT @WomenInLymphoma: ⚕️ @WomenInLymphoma Steering Committee members, advocates, sponsors and supporters from all over the world🌍networking….
0
13
0
@SFBarringtonKCL
Sally Barrington
8 months
RT @JohnPLeonardMD: Number 3 #LeonardList #ASH24 top #lymphoma abstract 235 – Lewis – Ibrutinib-R v chemo-R in pts w/untreated MCL (Enrich)….
0
3
0
@SFBarringtonKCL
Sally Barrington
8 months
RT @Hammers_Alexand: A great reminder that cutting-edge large axial field-of-view "#TotalBodyPET scanners not only allow entirely new resea….
0
1
0
@SFBarringtonKCL
Sally Barrington
8 months
RT @SciTechgovuk: Patients at @GSTTnhs will benefit from a full-body scanner that will enable more effective diagnosis of patients with ser….
0
24
0
@SFBarringtonKCL
Sally Barrington
8 months
RT @KingsImaging: Watch Dr @sohaibnazir, Clinical Senior Lecturer and Consultant Cardiologist at #Kingsimaging, explain how our new Total B….
0
3
0
@SFBarringtonKCL
Sally Barrington
9 months
RT @graham74GC: We see the elevation of glofitamab from 3rd line+ DLBCL to 2nd line+ combined with R-GemOx with STARGLO. Will it reach 1s….
0
13
0
@SFBarringtonKCL
Sally Barrington
9 months
RT @WomenInLymphoma: 👉Catch up with #IndolentLymphoma Session 3.@AnneSegolene @ClementineSar .🔗Recording #lymphoma….
0
8
0
@SFBarringtonKCL
Sally Barrington
9 months
Pr Catherine Thieblemont @LysaLymphoma @WomenInLymphoma @lymphoma_uk meeting - MTV & ENsites on PET and LDH used routinely to select for CART in France. Time for MTV in routine practice in UK with new international benchmark @KCLGSTTpet @KingsImaging
Tweet media one
0
8
17
@SFBarringtonKCL
Sally Barrington
9 months
Mike Bennett Memorial lecture from Pr Catherine Thieblemont @LysaLymphoma @WomenInLymphoma at UK lymphoma research group annual meeting @lymphoma_uk reports exciting times ahead as unprecedented anti tumor activity in RR DLBCL of CART and bispecifics moves into 1st line
Tweet media one
0
3
9
@SFBarringtonKCL
Sally Barrington
1 year
RT @KingsImaging: A new benchmark dataset to standardise the way Metabolic Tumour Volume (MTV) is measured in lymphoma patients is now publ….
Tweet card summary image
kcl.ac.uk
Researchers have established a new international benchmark for the measurement of tumour volume in lymphoma patients.
0
2
0
@SFBarringtonKCL
Sally Barrington
2 years
Article today in Lancet highlights only 1/3 invited lymphoma authors at top journals are women. Important perspective and suggestions for change from @WomenInLymphoma @eliza hawkes
Tweet card summary image
thelancet.com
Gender inequity in academic medicine is a well recognised problem that marginalises a crucial talent pool and ultimately diminishes innovation, collaboration, and progress.1,2 The international Women...
1
4
12